A bill to provide that members of the Advisory Committee on Immunization Practices may not be terminated except for cause and to require the immediate reinstatement of the members of such advisory committee.
- Bill Number
- S. 2483
- Origin Chamber
- Senate
- Congress
- 119th Congress, Session 1
- Policy Area
- Health
- Status
- Introduced
- Latest Action
- 2025-07-28: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Last Updated
- 2025-12-02T21:03:03Z
AI-Generated Summary
Purpose
This bill aims to protect the independence and stability of the Advisory Committee on Immunization Practices (ACIP), a federal advisory group that provides expert recommendations to the Department of Health and Human Services (HHS) on vaccines and immunization schedules. It prevents arbitrary dismissals of committee members and mandates the reinstatement of members who were in place before a specific recent date, ensuring continuity in public health advice.
Key Provisions
- Termination Restrictions: The HHS Secretary can only remove ACIP members "for cause," defined as inefficiency, neglect of duty, or malfeasance in office (serious misconduct). Removals require prior notice and an opportunity for a hearing.
- Justification Requirement: If a member is terminated for cause, the Secretary must submit a written explanation to the Senate Committee on Health, Education, Labor, and Pensions and the House Committee on Energy and Commerce, and make it publicly available, within one day of the termination.
- Protection for Federal Employees: For ACIP members who are also federal workers, termination from the committee does not affect their regular employment protections or status.
- Immediate Reinstatement: The bill requires restoring the ACIP membership to its state as of June 8, 2025, with those members serving out their original remaining terms (as of June 9, 2025).
- Future Appointments: Any vacancies after reinstatement must be filled by appointees recommended by the Comptroller General of the United States (an independent auditor who oversees government operations).
Significant Changes to Existing Law
- Prior to this bill, ACIP members could potentially be terminated at the discretion of the HHS Secretary without specific protections or requirements for justification. This legislation introduces due process (notice and hearing), limits terminations to specific causes, and mandates congressional notification and public transparency for any removals.
- It also shifts the process for filling vacancies by requiring recommendations from the Comptroller General, rather than solely from the Secretary, to reduce potential political influence in selections.
Potential Impacts
- On Government Agencies: Strengthens the autonomy of ACIP within HHS, potentially insulating vaccine policy recommendations from executive branch pressures. It may increase administrative burdens for the Secretary due to justification and hearing requirements.
- On Citizens: Could lead to more stable and expert-driven immunization guidelines, benefiting public health by maintaining consistent vaccine advice without sudden changes in committee composition. This might enhance trust in federal health recommendations.
- On International Relations: Minimal direct impact, though stable U.S. immunization policies could indirectly support global health efforts, such as those coordinated by the World Health Organization, by ensuring reliable domestic expertise.
Main Stakeholders Affected
- ACIP Members: Gain job security and due process protections, reducing vulnerability to dismissal.
- HHS Secretary and Department: Face new constraints on committee management, with added accountability to Congress and the public.
- Congressional Committees: Receive direct notifications on terminations, increasing their oversight role in public health advisory processes.
- Public Health Experts and Organizations: Benefit from a more independent ACIP, potentially leading to less politicized vaccine recommendations.
- General Public: Indirectly affected through more consistent and evidence-based immunization policies that influence vaccination programs and disease prevention.
Notable Legal, Constitutional, or Political Implications
- Legal: Introduces due process elements (notice and hearing) for advisory committee members, aligning with broader administrative law principles that protect against arbitrary government actions. The "for cause" standard provides a clear, narrow basis for terminations, which could be challenged in court if not followed.
- Constitutional: Reinforces separation of powers by involving Congress in oversight (via notifications) and an independent official (Comptroller General) in appointments, potentially checking executive authority over advisory bodies.
- Political: Addresses concerns about potential executive interference in scientific advisory committees, which has been a point of contention in recent administrations. By mandating reinstatement of pre-June 2025 members, it implicitly responds to specific past actions, promoting non-partisan stability in health policy amid debates over vaccine mandates and public trust.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Sen. Blunt Rochester, Lisa [D-DE]
Cosponsors (5)
Sen. Luján, Ben Ray [D-NM], Sen. Warnock, Raphael G. [D-GA], Sen. Heinrich, Martin [D-NM], Sen. Merkley, Jeff [D-OR], Sen. Alsobrooks, Angela D. [D-MD]
Recent Actions
- 2025-07-28: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- 2025-07-28: Introduced in Senate
Bill Versions
- To provide that members of the Advisory Committee on Immunization Practices may not be terminated except for cause and to require the immediate reinstatement of the members of such advisory committee. — issued 2025-07-28 — PDF (3 pages)